Literature DB >> 2770810

Inhibin as a marker for granulosa-cell tumors.

R E Lappöhn1, H G Burger, J Bouma, M Bangah, M Krans, H W de Bruijn.   

Abstract

Inhibin is a peptide hormone normally produced by ovarian granulosa cells. It reaches a peak of 772 +/- 38 U per liter in the follicular phase of the menstrual cycle and is undetectable in the serum of menopausal women. To determine whether measurements of serum inhibin levels would provide a biochemical marker of the presence or progression of ovarian granulosa-cell tumors and their metastases, we measured the serum immunoreactive inhibin concentrations in six women with such tumors. Three women had been treated by hysterectomy and bilateral salpingo-oophorectomy. In the two women with residual or recurrent disease, the serum inhibin levels were abnormally elevated 5 and 20 months before the clinical manifestations of recurrence became evident. The maximal concentrations approached 3000 U per liter. The serum inhibin level remained undetectable in one patient who was disease-free for 11 years. Serum inhibin concentrations were also elevated in three women with amenorrhea and infertility that resulted from small granulosa-cell tumors. After the removal of the tumors, the serum inhibin levels in these women became normal, and fertility returned. There was a significant negative correlation between the serum concentrations of inhibin and follicle-stimulating hormone, in a manner consistent with the autonomous production of inhibin by granulosa-cell tumors. We conclude that granulosa-cell tumors produce inhibin. Since serum inhibin levels reflect the size of the tumor, measurements of inhibin can be used as a marker for primary as well as recurrent disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2770810     DOI: 10.1056/NEJM198909213211204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  40 in total

1.  Alpha-inhibin expression in canine ovarian neoplasms: preliminary results.

Authors:  G Marino; P A Nicòtina; G Catone; R A Bontempo; A Zanghì
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

Review 2.  Recent advances in the human physiology of inhibin secretion.

Authors:  D M de Kretser; D M Robertson; G P Risbridger
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

3.  [Clinical utility of serous tumoural markers].

Authors:  A Martín Suárez; L Alonso Díaz; I Ordiz Alvarez; J Vázquez; F Vizoso Piñeiro
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 4.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

Review 5.  Multimodality imaging and genomics of granulosa cell tumors.

Authors:  Sherif Elsherif; Matthew Bourne; Erik Soule; Chandana Lall; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-03

Review 6.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

7.  Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.

Authors:  W G McCluggage; J Burton; P Maxwell; J M Sloan
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

8.  Constitutive Activation of PI3K in Oocyte Induces Ovarian Granulosa Cell Tumors.

Authors:  So-Youn Kim; Katherine Ebbert; Marilia H Cordeiro; Megan M Romero; Kelly A Whelan; Adrian A Suarez; Teresa K Woodruff; Takeshi Kurita
Journal:  Cancer Res       Date:  2016-05-09       Impact factor: 12.701

9.  Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell lines.

Authors:  Stacey Jamieson; Peter J Fuller
Journal:  Horm Cancer       Date:  2013-05-15       Impact factor: 3.869

10.  Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.

Authors:  Doris M Benbrook; Stan Lightfoot; James Ranger-Moore; Tongzu Liu; Shylet Chengedza; William L Berry; Igor Dozmorov
Journal:  Gene Regul Syst Bio       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.